EA202091821A1 - CD73 INHIBITORS - Google Patents

CD73 INHIBITORS

Info

Publication number
EA202091821A1
EA202091821A1 EA202091821A EA202091821A EA202091821A1 EA 202091821 A1 EA202091821 A1 EA 202091821A1 EA 202091821 A EA202091821 A EA 202091821A EA 202091821 A EA202091821 A EA 202091821A EA 202091821 A1 EA202091821 A1 EA 202091821A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibitors
pyridazin
pyrimidine
cycloalkyl
cancer
Prior art date
Application number
EA202091821A
Other languages
Russian (ru)
Inventor
Роберт Дин Дэлли
Мария Кристина Гарсия Паредес
Лоуренс Джозеф II Хайнц
Дженнифер Мари Хоувелл
Фрэнк Джордж Нджородж
Ян Ванг
Гэньши Чжао
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Priority claimed from PCT/US2019/019074 external-priority patent/WO2019168744A1/en
Publication of EA202091821A1 publication Critical patent/EA202091821A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В данном изобретении предложены соединения 5-[5-[2-циклоалкил]-6-пиридазин-3-ил]-1H-пиримидин-2,4-диона или их фармацевтически приемлемые соли, которые ингибируют активность CD73 и пригодны для лечения рака.The present invention provides 5- [5- [2-cycloalkyl] -6-pyridazin-3-yl] -1H-pyrimidine-2,4-dione compounds, or pharmaceutically acceptable salts thereof, which inhibit CD73 activity and are useful in the treatment of cancer.

EA202091821A 2018-12-05 2019-02-22 CD73 INHIBITORS EA202091821A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862775553P 2018-12-05 2018-12-05
PCT/US2019/019074 WO2019168744A1 (en) 2018-03-01 2019-02-22 Cd73 inhibitors

Publications (1)

Publication Number Publication Date
EA202091821A1 true EA202091821A1 (en) 2020-11-23

Family

ID=73649870

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091821A EA202091821A1 (en) 2018-12-05 2019-02-22 CD73 INHIBITORS

Country Status (1)

Country Link
EA (1) EA202091821A1 (en)

Similar Documents

Publication Publication Date Title
CY1125145T1 (en) CD73 INHIBITORS
EA202092590A1 (en) PYRIDAZINONES AS PARP7 INHIBITORS
CY1123810T1 (en) TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS KALLIKREIN INHIBITORS IN HUMAN PLASMA
GEP20237506B (en) Pcsk9 antagonist compounds
EA201891057A1 (en) COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY
EA201891494A1 (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
EA201790170A1 (en) THERAPEUTIC COMPOUNDS INHIBITORS
BR112017003054A2 (en) aminopyrimidinyl compounds as jak inhibitors
EA201591509A1 (en) CDC7 INHIBITORS
EA201692079A1 (en) INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1
MX2023002507A (en) Cd73 inhibitors.
EA201791289A1 (en) INHIBITORS OF CELLULAR NECROSIS AND RELATED METHODS
PH12020552214A1 (en) Ectonucleotidase inhibitors and methods of use thereof
EA201692470A1 (en) PHARMACEUTICAL COMBINATIONS
NZ788133A (en) Cd73 inhibitors
CY1124907T1 (en) KALLIKREIN INHIBITORS IN HUMAN PLASMA
EA202191476A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA202090424A1 (en) BICYCLIC HISTONDEACETYLASE INHIBITORS
EA202191192A1 (en) CRYSTALLINE SALTS OF PLASMA CALLICREIN INHIBITOR
EA201891240A1 (en) 1,3,4-TIADIAZOLIC COMPOUNDS AND THEIR APPLICATION IN THE TREATMENT OF CANCER
EA202091821A1 (en) CD73 INHIBITORS
EA201792676A1 (en) JAK1 INHIBITORS
EA201990042A1 (en) COMPOSITIONS CONTAINING TIMOLOL AND ANTI-INFLAMMATORY AGENT
EA201991141A1 (en) AMPLIFIERS BMP
EA201990443A1 (en) NEW APPLICATION OF N, N-BIS-2 -MERCAPTOETHYLISOPHTHALAMIDE